Scott Mendel
Director/Board Member at AKOYA BIOSCIENCES, INC.
Net worth: 337 237 $ as of 2024-04-29
Profile
Mr. Scott Mendel is an Independent Director at Akoya Biosciences, Inc. He is on the Board of Directors at Quantum-Si, Inc., Agendia, Inc., Akoya Biosciences, Inc. and Visby Medical, Inc. Mr. Mendel was previously employed as a President & Chief Executive Officer by GenMark Diagnostics, Inc., a Chief Financial Officer by Active Network LLC, and a CFO-Healthcare Information Technology Division by General Electric Co. He received his undergraduate degree from Indiana University and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-15 | 141,843 ( 0.12% ) | 228 367 $ | 2024-04-29 | |
AKOYA BIOSCIENCES INC
0.06% | 2024-03-30 | 28,500 ( 0.06% ) | 108 870 $ | 2024-04-29 |
Scott Mendel active positions
| Companies | Position | Start |
|---|---|---|
| AKOYA BIOSCIENCES, INC. | Director/Board Member | 2021-06-10 |
| QUANTUM-SI INCORPORATED | Director/Board Member | 2023-05-14 |
Visby Medical, Inc.
 Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Director/Board Member | 2022-01-03 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Director/Board Member | 2022-01-05 |
Former positions of Scott Mendel
| Companies | Position | End |
|---|---|---|
| ACTIVE NETWORK INC | Director of Finance/CFO | 2013-11-30 |
| GE AEROSPACE | Corporate Officer/Principal | 2010-02-28 |
| GENMARK DIAGNOSTICS, INC. | Chief Executive Officer | - |
Training of Scott Mendel
| Indiana University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GE AEROSPACE | Producer Manufacturing |
| AKOYA BIOSCIENCES, INC. | Health Technology |
| QUANTUM-SI INCORPORATED | Technology Services |
| Private companies | 4 |
|---|---|
Active Network LLC
 Active Network LLC Packaged SoftwareTechnology Services Active Network LLC engages in cloud based activity and participant management solutions. It offers software solutions for race management, recreation management, outdoor management, camp management, church management, ski and attractions, sports management, school management, and swim management. The company was founded by Scott Galen Kyle, Mitchell F. Thrower, David Alberga, and Jim Woodman in 1999 and is headquartered in Dallas, TX. | Technology Services |
GenMark Diagnostics, Inc.
 GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA. | Health Technology |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Health Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
- Stock Market
- Insiders
- Scott Mendel
